# Quality Assurance Report

---

# Identity

| Field | Value |
|-------|-------|
| QA Report ID | QA-PP-0143 |
| Population Package | PP-0143 |
| Version | 1.0.0 |
| Review Status | PASS |

---

# Layer 1 — Content QA

| Criterion | Result |
|-----------|--------|
| Single educational question | PASS |
| Scope respected | PASS |
| Complete coverage | PASS |
| Internal consistency | PASS |
| Logical organization | PASS |
| Knowledge blocks complete | PASS |
| No overlap with adjacent Population Packages | PASS |
| Historical/current distinction preserved | PASS |

---

# Layer 2 — Clinical QA

| Criterion | Result |
|-----------|--------|
| Scientifically accurate | PASS |
| Consistent with ACMG | PASS |
| Consistent with AMP | PASS |
| Consistent with ClinGen SVI | PASS |
| Consistent with ClinGen SVI Splicing Subgroup | PASS |
| Appropriate explanation of synonymous variants | PASS |
| Appropriate explanation of RNA splicing | PASS |
| Appropriate explanation that synonymous does not automatically mean benign | PASS |
| Appropriate explanation of variant-location relevance | PASS |
| Appropriate representation of current BP7 refinement | PASS |
| Appropriate distinction between supporting evidence and final classification | PASS |
| No unsupported clinical claim | PASS |
| No unsafe medical advice | PASS |

---

# Layer 3 — Educational QA

| Criterion | Result |
|-----------|--------|
| Plain language | PASS |
| Appropriate for patients | PASS |
| Learning objectives satisfied | PASS |
| Common misconceptions addressed | PASS |
| "Silent = harmless" misconception explicitly corrected | PASS |
| Splicing concept explained without unnecessary technical detail | PASS |
| Current governance clearly distinguished from historical wording | PASS |
| Appropriate clarification that BP7 is supporting evidence only | PASS |

---

# Layer 4 — Governance QA

| Criterion | Result |
|-----------|--------|
| CKO completed | PASS |
| Knowledge Passport completed | PASS |
| Evidence Package completed | PASS |
| Evidence traceability complete | PASS |
| Scope maintained | PASS |
| Knowledge Graph complete | PASS |
| Versioning complete | PASS |
| Repository compliant | PASS |
| Current ClinGen refinement encoded | PASS |

---

# Clinical Safety Review

| Item | Result |
|------|--------|
| No unsafe medical advice | PASS |
| No statement that all synonymous variants are benign | PASS |
| Splicing risk appropriately acknowledged | PASS |
| Variant-location context appropriately acknowledged | PASS |
| No universal gene-specific rule presented | PASS |
| BP7 not presented as definitive benign classification | PASS |
| Expert interpretation remains necessary | PASS |
| No treatment recommendations | PASS |

---

# Educational Boundary Review

The Population Package successfully remains within the predefined educational boundary.

### Included

- BP7 definition
- Synonymous/silent variants
- RNA splicing
- Computational splicing evidence
- Variant location
- Supporting Benign Evidence
- Current ClinGen SVI refinement
- Patient implications

### Excluded

- SpliceAI methodology
- MaxEntScan
- Individual prediction algorithms
- RNA sequencing
- RT-PCR
- Minigene assays
- Detailed splice-position calculations
- BP7_Strong(RNA) implementation
- Gene-specific BP7 specifications
- Bayesian framework
- ACMG evidence combination rules
- Laboratory workflow
- Treatment recommendations

The **Atomic Knowledge Principle** has been fully preserved.

---

# Runtime Safety Review

The package establishes the following safety boundary:

> **A synonymous variant is not automatically harmless.**

The Safe Medical AI System must therefore avoid generating statements such as:

- "Silent variants cannot cause disease."
- "A synonymous variant is automatically benign."
- "BP7 proves that the variant has no biological effect."

Instead, the system should explain that appropriate evidence regarding **splicing and gene function** is required before BP7 can contribute supporting benign evidence.

---

# Final Quality Decision

## PASS

PP-0143 satisfies the locked **Gold Population Package Specification v1.0**.

Approved as the official Population Package for:

> **PP-0143 — BP7 (Synonymous Variant with No Impact on Splicing or Gene Function)**

---

# Reviewer Notes

This Population Package addresses an important patient-safety misconception: **"synonymous" or "silent" does not necessarily mean biologically silent**.

The package correctly distinguishes the original ACMG/AMP BP7 definition from subsequent ClinGen SVI splicing-specific refinement. It also avoids exposing patients to unnecessary algorithmic detail while preserving the clinically important role of RNA splicing and variant location.

The package therefore maintains strict adherence to the **Atomic Knowledge Principle**, while providing an appropriate foundation for future Population Packages addressing splice prediction, RNA evidence, and functional splicing assays.